TRIB logo

Trinity Biotech (TRIB)

Profile

Full Name

Trinity Biotech plc

Ticker Symbol

TRIB

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

Ireland

IPO

October 21, 1992

Indexes

Not included

Website

http://www.trinitybiotech.com

Employees

380

Key Details

Price

$0.58(0.00%)

Market cap

Last Dividend

$1.10

TTM Dividend yield

-

Annual revenue

$56.83M(-9.10% YoY)

Annual EPS

-$3.20(+46.67% YoY)

PE ratio

-

Next earnings date

May 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.58
TRIB price is $0.58

30-Day Relative Volume

0.35
TRIB 30-day relative volume is 0.35

Price Performance

Price Most recent change

0%
TRIB {parameterFullLabel} has remained unchanged on Apr 14, 2025

Price YTD change

-34.09%
TRIB price is down -34.09% since January 1st

Price 1-year change

-69.63%
TRIB price is down -69.63% year-on-year

Price 3-year change

-90.49%
TRIB price is down -90.49% over the past 3 years

Price Range

Price All-time high

$151.88
TRIB price is currently -99.62% below its historical high of $151.88

Price 3-year low

$0.48
TRIB price is currently +20.83% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.13M
TRIB market capitalization is $11.13 million

Market cap 3-year change

-66.1%
TRIB market capitalization is down -66.1% over the past 3 years

Market cap All-time high

$643.07M
TRIB market capitalization is currently -98.27% below its historical high of $643.07 million

Market cap sector rank

21.05%
TRIB market capitalization is higher than 21.05% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+102.78%
TRIB shares outstanding is up +102.78% year-on-year

Shares Outstanding 3-Year Change

+359.16%
TRIB shares outstanding is up +359.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
TRIB beta is 0.43

200-day SMA

$1.43
TRIB price is currently -59.58% below its 200-day simple moving average

50-day SMA

$0.70
TRIB price is currently -17.17% below its 50-day simple moving average

RSI

42.11
TRIB 14-day relative strength index is 42.11

Volume

0.35
TRIB 30-day relative volume is 0.35

ATR

$0.06
TRIB average true range is $0.06

10-day Historical Volatility

60.28%
TRIB 10-day historical volatility is 60.28%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.10
TRIB last dividend was $1.10 per share, with an ex-dividend date of June 5, 2015

Next Dividend

-
TRIB next dividend has not yet been announced

Dividend per share

Dividend per share

-
TRIB annual dividend per share value is unknown

Dividend per share Sector Rank

-
TRIB annual dividend per share is unknown

Dividend per share 1-Year Change

-
TRIB annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
TRIB annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
TRIB annual dividend yield value is unknown

Dividend yield Sector Rank

-
TRIB annual dividend yield is unknown

Other

Payout ratio

0.00%
TRIB annual payout ratio is 0.00%

Dividends paid

$0.00
TRIB annual dividends paid is $0.00

Free cash flow

-$14.26M
TRIB annual free cash flow is -$14.26 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$56.83M
TRIB annual revenue is $56.83 million

Revenue Analysts estimate

$62.20M
TRIB annual revenue is currently -8.63% lower than the consensus analysts' forecast

Revenue 1-year change

-9.1%
TRIB annual revenue is down -9.1% year-on-year

Revenue Sector rank

48.71%
TRIB annual revenue is higher than 48.71% of companies in Healthcare sector

EPS

EPS

-$3.20
TRIB annual earnings per share is -$3.20

EPS Analysts estimate

-$1.74
TRIB annual earnings per share is currently +83.91% higher than the consensus analysts' forecast

EPS 1-year change

+46.67%
TRIB annual earnings per share is up +46.67% year-on-year

EPS Sector rank

27.87%
TRIB annual earnings per share is higher than 27.87% of companies in Healthcare sector

Profit

Gross profit

$19.45M
TRIB annual gross profit is $19.45 million

Gross margin

34.22%
TRIB annual gross profit margin is 34.22%

Operating profit

-$15.94M
TRIB annual operating income is -$15.94 million

Operating margin

-28.05%
TRIB annual operating profit margin is -28.05%

Net income

-$24.02M
TRIB annual net profit is -$24.02 million

Net margin

-42.26%
TRIB annual net profit margin is -42.26%

Expenses

Total expenses

$72.77M
TRIB annual total expenses is $72.77 million

Operating expenses

$35.39M
TRIB annual total operating expenses is $35.39 million

Cost of goods sold

$37.38M
TRIB annual cost of goods sold is $37.38 million

Selling, general & administrative expenses

$31.15M
TRIB annual SGA is $31.15 million

Depreciation and amortization

$1.78M
TRIB annual depreciation & amortization is $1.78 million

Interest expense

$10.15M
TRIB annual interest expense is $10.15 million

Income tax

-$59.00K
TRIB annual income tax is -$59.00 thousand

EBIT & EBITDA

EBIT

-$25.87M
TRIB annual earnings before interest & taxes is -$25.87 million

EBITDA

-$24.10M
TRIB annual EBITDA is -$24.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$59.44M
TRIB annual total assets is $59.44 million

Non current assets

$20.39M
TRIB annual long term assets is $20.39 million

Current assets

$39.04M
TRIB annual total current assets is $39.04 million

Cash and cash equivalents

$3.69M
TRIB annual cash & cash equivalents is $3.69 million

Accounts receivable

$10.70M
TRIB annual accounts receivable is $10.70 million

Inventory

$19.93M
TRIB annual inventory is $19.93 million

Liabilities

Total liabilities

$83.38M
TRIB annual total liabilities is $83.38 million

Long term liabilities

$68.35M
TRIB annual total long term liabilities is $68.35 million

Current liabilities

$15.04M
TRIB annual total current liabilities is $15.04 million

Accounts payable

$14.50M
TRIB annual accounts payable is $14.50 million

Debt

Total debt

$54.86M
TRIB annual total debt is $54.86 million

Total debt 1-year change

-24.02%
TRIB annual total debt is down -24.02% year-on-year

Long term debt

$54.65M
TRIB annual long term debt is $54.65 million

Short term debt

$210.00K
TRIB annual short term debt is $210.00 thousand

Equity & Capital

Shareholders equity

-$23.95M
TRIB annual stockholders equity is -$23.95 million

Book value

-$23.95M
TRIB annual book value is -$23.95 million

Retained earnings

-$48.64M
TRIB annual retained earnings is -$48.64 million

Working capital

$24.01M
TRIB annual working capital is $24.01 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.56M
TRIB annual cash flow from operations is -$11.56 million

Cash from operations 1-year change

-1154.83%
TRIB annual cash flow from operations is down -1154.83% year-on-year

Cash from investing

$24.76M
TRIB annual cash flow from investing activities is $24.76 million

Cash from investing 1-year change

+514.19%
TRIB annual cash flow from investing activities is up +514.19% year-on-year

Cash from financing

-$16.04M
TRIB annual cash flow from financing activities is -$16.04 million

Cash from financing 1-year change

-30.19%
TRIB annual cash flow from financing activities is down -30.19% year-on-year

CAPEX

CAPEX

$2.70M
TRIB annual capital expenditures is $2.70 million

CAPEX 1-year change

-54.76%
TRIB annual capital expenditures is down -54.76% year-on-year

Free Cash Flow

Free cash flow

-$14.26M
TRIB annual free cash flow is -$14.26 million

Free cash flow 1-year change

-106.74%
TRIB annual free cash flow is down -106.74% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

34.22%
TRIB annual gross profit margin is 34.22%

Operating margin

-28.05%
TRIB annual operating profit margin is -28.05%

Net margin

-42.26%
TRIB annual net profit margin is -42.26%

ROA & ROE

ROA

-31.70%
TRIB annual return on assets is -31.70%

ROE

100.29%
TRIB annual return on equity is 100.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TRIB price to earnings ratio value is unknown

PE ratio Sector rank

-
TRIB price to earnings ratio is unknown

PB Ratio

PB ratio

-0.42
TRIB price to book ratio is -0.42

PB ratio Sector rank

10.7%
TRIB price to book ratio is higher than 10.7% of companies in Healthcare sector

PS Ratio

PS ratio

0.19
TRIB price to sales ratio is 0.19

PS ratio Sector rank

7.56%
TRIB price to sales ratio is higher than 7.56% of companies in Healthcare sector

Enterprise value

Enterprise value

-
TRIB enterprise value value is unknown

Enterprise value Sector rank

-
TRIB enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
TRIB EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
TRIB EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.60
TRIB annual current ratio is 2.60

Quick ratio

1.27
TRIB annual quick ratio is 1.27

Leverage

Debt to equity

-2.29
TRIB annual debt to equity ratio is -2.29

Interest coverage ratio

-2.55
TRIB annual interest coverage ratio is -2.55

Risk & Stability

Piotroski F-Score

2
TRIB piotroski f-score is 2

Altman Z-Score

-1.06
TRIB altman z-score is -1.06

Analyst ratings

Recent major analysts updates

Oct 5, 16 Stephens & Co.
Equal-weight
May 29, 15 Stephens & Co.
Overweight
Apr 30, 14 Roth Capital
Buy
Mar 5, 13 Craig-Hallum
Buy
Jan 22, 13 Roth Capital
Neutral
Dec 11, 12 CJS Securities
Market Outperform

Institutional Ownership

Similar stocks

BSGM logo
BioSig Technologies (BSGM)
RLYB logo
Rallybio (RLYB)
MBRX logo
Moleculin Biotech (MBRX)
ICU logo
SeaStar Medical Holding (ICU)
ABVC logo
ABVC BioPharma (ABVC)
GOVX logo
GeoVax Labs (GOVX)
ERNA logo
Eterna Therapeutics (ERNA)
NERV logo
Minerva Neurosciences (NERV)
PSTV logo
Plus Therapeutics (PSTV)
  • What is the ticker symbol for Trinity Biotech?
  • Does Trinity Biotech pay dividends?
  • What sector is Trinity Biotech in?
  • What industry is Trinity Biotech in?
  • What country is Trinity Biotech based in?
  • When did Trinity Biotech go public?
  • Is Trinity Biotech in the S&P 500?
  • Is Trinity Biotech in the NASDAQ 100?
  • Is Trinity Biotech in the Dow Jones?
  • When was Trinity Biotech's last earnings report?
  • When does Trinity Biotech report earnings?
  • Should I buy Trinity Biotech stock now?

What is the ticker symbol for Trinity Biotech?

The ticker symbol for Trinity Biotech is NASDAQ:TRIB

Does Trinity Biotech pay dividends?

No, Trinity Biotech does not pay dividends

What sector is Trinity Biotech in?

Trinity Biotech is in the Healthcare sector

What industry is Trinity Biotech in?

Trinity Biotech is in the Medical Devices industry

What country is Trinity Biotech based in?

Trinity Biotech is headquartered in Ireland

When did Trinity Biotech go public?

Trinity Biotech's initial public offering (IPO) was on October 21, 1992

Is Trinity Biotech in the S&P 500?

No, Trinity Biotech is not included in the S&P 500 index

Is Trinity Biotech in the NASDAQ 100?

No, Trinity Biotech is not included in the NASDAQ 100 index

Is Trinity Biotech in the Dow Jones?

No, Trinity Biotech is not included in the Dow Jones index

When was Trinity Biotech's last earnings report?

Trinity Biotech's most recent earnings report was on Nov 15, 2024

When does Trinity Biotech report earnings?

The next expected earnings date for Trinity Biotech is May 23, 2025

Should I buy Trinity Biotech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page